학술논문
Exclusive antagonism of the α4 β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates.
Document Type
Article
Author
Source
Inflammatory Bowel Diseases; Nov2012, Vol. 18 Issue 11, p2107-2119, 13p
Subject
Language
ISSN
10780998